The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it hold, with a mean price target of $255.
FactSet
FDS · a US exchange · USD · Market cap $9.4B · 12,840 employees
FactSet Research Systems Inc., together with its subsidiaries, operates as a financial digital platform and enterprise solutions provider for the investment community.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
FactSet holds its Distribution at $262.93. Consolidating, no directional conviction, held for 19 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 19 days |
| Price at the screen | $262.93 |
| Valuation | 17.31 trailing · 13.34 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.71 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 4% discount to our $274.61 fair value, strong competitive moat, 6.40% revenue growth.
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 4.4% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Hold. The average target sits −4% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsData platform trips on ethics test
Every fund manager tapping a terminal for clean company data or portfolio numbers relies on a handful of specialist platforms that sit between raw filings and real decisions. FactSet built one of the stronger ones, with a genuine moat, 27 percent ROE, and 23 percent margins that most software names would envy. Yet the numbers still point to a pass.
We are staying away first because the business fails our ethical screen on activity grounds. That screen exists for exactly these cases, and no amount of operational quality overrides it. The modest 5 percent margin of safety at the current price and the 6 percent revenue growth simply do not change the call.
Analysts already see limited upside, with a median target below the current level and a hold rating across the board. Forward earnings sit at 13 times, which looks reasonable until you remember the ethical red line sits in front of any valuation debate. Analysis, not advice.
| Forward P/E | 13.3xexpensive even after accounting for its growth |
| Trailing P/E | 17.3xreasonably valued |
| EPS, trailing | 15.19 |
| EPS, forward | 19.71 |
| Revenue growth | +6.4%slow but positive growth |
| Profit margin | 23.2%healthy profit margins |
| Return on equity | 27.0%an exceptional return on shareholder capital |
| FCF yield | 6.64% |
| Dividend yield | 208.00% |
| Debt to equity | 0.77moderate, manageable leverage |
| Current ratio | 0.68below 1: short-term bills exceed liquid assets |
| Beta | 0.71steadier than the market |
| Short interest, float | 0.12% |
| 52-week range | 185.00 - 370.98 |
| Moat | STRONG |
| Market cap | $9.4B |
| Employees | 12,840 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFDS trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it hold, with a mean price target of $248.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it hold, with a mean price target of $248.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | WARREN JOSHUA | Chief Financial Officer | 2,272 | · | |
| 2026-01-15 | FRANK MALCOLM | Director | 713 | · | |
| 2026-01-15 | ABRAMS ROBIN ANN | Director | 604 | · | |
| 2026-01-15 | HYLTON LAURIE G | Director | 439 | · | |
| 2026-01-15 | SIEGEL LAURIE A | Director | 626 | · | |
| 2026-01-15 | SHAVEL LEE M | Director | 571 | · | |
| 2026-01-15 | EILAM BARAK | Director | 439 | · | |
| 2026-01-15 | CHOY SIEW KAI | Director | 439 | · | |
| 2026-01-15 | TEJADA MARIA TERESA | Director | 439 | · | |
| 2026-01-15 | WIESEL SHLOMO ELISHA | Director | 571 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-19 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-19 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-19 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-19 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-19 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $218.13 | +12.7% | $1.16 | $1,132 | +13.2% |
| 2 months | $210.57 | +16.7% | $1.16 | $1,173 | +17.3% |
| 3 months | $202.61 | +21.3% | $1.16 | $1,219 | +21.9% |
| 6 months | $288.64 | -14.9% | $2.26 | $859 | -14.1% |
| 1 year | $418.46 | -41.3% | $4.46 | $598 | -40.2% |
| 2 years | $395.74 | -37.9% | $8.68 | $643 | -35.7% |
| 3 years | $383.79 | -36.0% | $12.66 | $673 | -32.7% |
| 5 years | $311.65 | -21.1% | $19.66 | $852 | -14.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FDS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.